Home » Topics » Regulatory

Regulatory
RSS

Cephalosporin tested in Italian patients with ALS

Oct. 25, 1996

First and only Estrophasic oral contraceptive approved

Oct. 18, 1996

Serono's recombinant human growth hormone approved

Oct. 18, 1996

First low-dose hydrochlorothiazide product approvable

Oct. 18, 1996

Antihypertensive combination cleared for marketing in the U.S.

Oct. 18, 1996

First approval for Astra asthma product

Oct. 18, 1996

Schering-Plough's Claritin line expanded

Oct. 18, 1996

Dimethaid seeks approval for treatment for arthritic pain

Oct. 18, 1996

Improved formulation of Testoderm available in U.S.

Oct. 11, 1996

Muse approvable for treatment of impotence

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...